Visit to the FDA
In the week of 15-18 May 2017 the Avicenna Alliance was in Washington DC, following an invitation by the FDA and by the staff of Senator T. Cochran to discuss the role of in silico medicine.
The Delegation consisted of Avicenna Alliance Members, an EMA Representative, FDA Representatives, US-Avicenna Contacts, US Senate Staff and the RPP Group.
On the first day of the US trip the Avicenna Alliance delegation had the opportunity to hear about the vision of the FDA in terms of Computation Modeling and Simulation and, in turn, to present Avicenna Members’ visions from a medical device (Medtronic- Markus Reiterer), pharmaceuticals (Johnson and Johnson- Céline Bourguignon), software (ANSYS- Thierry Marchal) and Academic (KU Leuven and Liege- Prof. Liesbet Geris) perspectives to the FDA staff.
Another very insightful part of the day was a tour of the FDA Facilities, Labs and Explanation of the work of different sections.